Nolvadex and Occlusion - renal artery - from FDA reports
There is no Occlusion - renal artery reported by people who take Nolvadex yet. This review analyzes which people have Occlusion - renal artery with Nolvadex. It is created by eHealthMe based on reports from FDA, and is updated regularly.
No report is found.
Do you take Nolvadex and have Occlusion - renal artery?
- Check whether a drug or a condition causes Occlusion - renal artery
- Get paid with your care experience as a Care Guide
- Connect with people like you, or share your experience to help people like you
- Print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Nolvadex has active ingredients of tamoxifen citrate. It is often used in breast cancer. (latest outcomes from Nolvadex 5,003 users)
Occlusion - Renal Artery
Occlusion - renal artery (a blockage of the major arteries that supply blood to the kidneys) has been reported by people with high blood pressure, kidney transplant, high blood cholesterol, diabetes (latest reports from 1,802 Occlusion - renal artery patients).
Drugs that are associated with Occlusion - renal arteryOcclusion - renal artery
Could your condition cause Occlusion - renal arteryOcclusion - renal artery
Nolvadex side effects
- Nolvadex side effects (4,941 reports)
Browse all side effects of Nolvadexa b c d e f g h i j k l m n o p q r s t u v w x y z
What would happen?
You are not alone. Join our personalized support groups:
- Support group for people who take Nolvadex and have Occlusion - Renal Artery
- Support group for people who have Occlusion - Renal Artery
- Support group for people who take Nolvadex
- Will you have Opiates Positive with Blood Iron Decreased?
- Will you have Raynaud'S Disease with Minocycline Hydrochloride?
- Will you have Weakness with Cotazym?
- Moxifloxacin and Humira drug interaction
- Will you have Injection Site Bruising with Humalog Pen?
Active Support Groups
- Support group for people who have Blood Iron Decreased and Opiates Positive?
- Support group for people who take Minocycline Hydrochloride and have Raynaud'S Disease?
- Support group for people who take Cotazym and have Weakness?
- Support group for people who take Moxifloxacin and Humira
- Support group for people who take Humalog Pen and have Injection Site Bruising?
- What to expect when you have Blood Iron Decreased and Opiates Positive?
- What to expect when you take Minocycline Hydrochloride and have Raynaud'S Disease?
- What to expect when you take Cotazym and have Weakness?
- What to expect when you take Moxifloxacin and Humira
- What to expect when you take Humalog Pen and have Injection Site Bruising?
- A study for a 51 year old woman who takes Humira, Imuran
- A study for a 39 year old woman who takes Chantix
- A study for a 60 year old man who takes Tresiba
- A study for a 46 year old woman who takes Effexor, Prozac
- A study for a 31 year old woman who takes Liothyronine Sodium, Levothyroxine Sodium
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.